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ABSTRACT
Most RNA viruses infecting mammals and other ver-
tebrates show profound suppression of CpG and
UpA dinucleotide frequencies. To investigate this
functionally, mutants of the picornavirus, echovirus
7 (E7), were constructed with altered CpG and UpA
compositions in two 1.1–1.3 Kbase regions. Those
with increased frequencies of CpG and UpA
showed impaired replication kinetics and higher
RNA/infectivity ratios compared with wild-type
virus. Remarkably, mutants with CpGs and UpAs
removed showed enhanced replication, larger
plaques and rapidly outcompeted wild-type virus
on co-infections. Luciferase-expressing E7 sub-
genomic replicons with CpGs and UpAs removed
from the reporter gene showed 100-fold greater lu-
minescence. E7 and mutants were equivalently sen-
sitive to exogenously added interferon-b, showed no
evidence for differential recognition by ADAR1 or
pattern recognition receptors RIG-I, MDA5 or PKR.
However, kinase inhibitors roscovitine and C16 par-
tially or entirely reversed the attenuated phenotype
of high CpG and UpA mutants, potentially through
inhibition of currently uncharacterized pattern rec-
ognition receptors that respond to RNA compos-
ition. Generating viruses with enhanced replication
kinetics has applications in vaccine production and
reporter gene construction. More fundamentally, the
findings introduce a new evolutionary paradigm
where dinucleotide composition of viral genomes
is subjected to selection pressures independently
of coding capacity and profoundly influences host–
pathogen interactions.
INTRODUCTION
Studies of RNA viruses provide major insights and func-
tional understanding of replication mechanisms and host
cellular interactions in which processes of mutation,
ﬁtness selection, recombination and sequence drift can
be directly observed. The small size and necessarily
compact arrangement of protein-coding sequences and
replication elements creates a range of constraints on
sequence change that are frequently both quantitatively
and qualitatively different from evolutionary selection
pressures on their eukaryotic and prokaryotic hosts.
Coding regions of RNA virus genomes frequently
contain secondary and higher order RNA structures that
function as points of interaction with viral and host
cellular proteins and RNA elements such as ribosomes
(1,2). For example, cis-replicating elements of
enteroviruses in the 2C-coding region and of hepatitis C
virus in NS5B are revealed by a marked suppression of
sequence variability at largely unconstrained synonymous
coding sites (3,4). Substitutions in base-paired nucleotides
in the stem loop are selected against if they damage the
stability of pairing, and changes are often accompanied by
compensatory changes in the paired residue to restore
pairing. Many RNA viruses have also evolved additional
genes to inhibit or divert innate cell defences, typically
embedded within other viral genes in alternative reading
frames (5), such as the PB1-F2 protein of inﬂuenza A virus
(6). These interactions place further constraints on virus
sequence change in coding regions of RNA viruses over
and above their protein-coding function.
While these additional RNA-structure- or protein-
coding-based constraints are relatively well understood
in viruses where replication mechanisms are characterized,
RNA virus genomes additionally evolve under a series of
additional compositional constraints for which functional
explanations are currently lacking. RNA viral genomes
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show an extremely wide range of base compositions;
among mammalian viruses, G+C contents range from
as low as 33% (respiratory syncytial virus) to 69.9%
(rubella virus). Coding regions of RNA viruses frequently
show highly abnormal codon usage patterns (7); hepatitis
A virus show highly restricted codon usage [formally
quantiﬁed by measures such as an effective number of
codons [Enc] of 39.8; (8)] and codon choices different
from mammalian usage [measured as a codon adaptation
index of 0.76; (9)].
However, one of the most unexpected compositional
abnormalities, particularly among RNA and small DNA
viruses infecting mammals and plants, is the markedly
biased frequencies of certain dinucleotides such as CpG
and UpA throughout their genomes (10–12). For example,
poliovirus shows a frequency of CpG dinucleotides in its
coding region that is only 54% of the expected value
calculated from its (mononucleotide) composition (based
on a 23.5% [frequency of G] 23.4% [frequency of C]).
UpA is similarly suppressed (74% of expected value) while
other dinucleotides are over-represented (CpA: 1.32;
UpG: 1.35). The lack of suppression of GpC and ApU
in RNA viruses (and host genomes) demonstrates that this
effect is speciﬁc to CpG and UpA and does not simply
reﬂect evolutionary pressure for regions of greater or
lesser duplex stability.
The overlap between dinucleotides creates inter-
dependencies that complicate analysis of the mutational
and selection pressures that underlie these biased compos-
itional frequencies. For example, the methylation-
associated elimination of CpG dinucleotides through
C->T transitions in genomic dsDNA creates TpG and
ApC dinucleotides, a process that potentially accounts
for their over-representation in vertebrate DNA (10) and
indirectly depletes TpA (13). We recently developed a
parameterized Markov method to identify what further
dinucleotide context-dependent mutations best account for
compositional patterns in genomic and cytoplasmically
expressed mRNA sequences of mammals and a range
of other eukaryotic phyla. This was extended to analyse
compositional abnormalities of RNA viruses infecting
mammals and insects (10). As expected, 11- to 14-fold
greater frequencies of C!T transitions upstream of G
(depicted C!T,G) than other transitions best modelled
dinucleotide frequencies in mammalian genomic DNA.
Additionally, further mutations that eliminated UpA di-
nucleotides and CpG dinucleotides were observed in the
subset of sequences expressed as mRNA and entering the
cytoplasm. Modelling provided evidence for equivalent
selection against these dinucleotides in mammalian and
plant RNA viruses that is consistent with their under-
representation in previous compositional analyses
(10,11,14). The nature of this apparent selection against
CpG dinucleotides operating on both host and viral cyto-
plasmic RNA sequences remains unexplained functionally
although it has been frequently hypothesized that recog-
nition of CpG and potentially UpA motifs is part of an as
yet uncharacterized self–non-self recognition system
coupled to innate immunity (15). This may be functionally
and perhaps evolutionarily related to Toll-like receptor 9
that recognizes non-methylated CpG dinucleotides in
DNA sequences (14,16).
Further evidence that the presence of CpG dinucleo-
tides in viral sequences either activate or are targets of
cell defence mechanisms is provided by the observation
that polioviruses with artiﬁcially elevated CpG frequencies
in their genomic RNA were markedly attenuated and
replicated to titres several orders of magnitude lower
than wild-type virus in vitro (17). The existence of such
recognition systems may in turn have placed additional
selection pressures on host expressed mRNA sequences
to evade these viral countermeasures. In the current
study, we have developed a model system based on an
infectious clone of the enterovirus, echovirus 7 (E7), to
investigate the effect of modifying dinucleotide frequencies
on virus replication in mammalian cells. The observation
that elevated frequencies of both UpA and CpG attenuate
viral replication while lowering frequencies below those of
native viral sequences enhances replication provided the
opportunity to investigate the role of different compo-
nents of the innate immune system in dinucleotide recog-
nition and recruitment of antiviral defences.
MATERIALS AND METHODS
Cell culture and cell lines
RNA transcripts of the pT7:E7 infectious cDNA clone of
the isolate Wallace (accession number AF465516) and
pRiboE7luc replicon were used to generate E7 viral
stocks and the E7 replicon used in the study. Both were
propagated in rhabdomyosarcoma (RD) cells using
Dulbecco modiﬁed Eagle medium (DMEM) with 10%
fetal calf serum (FCS), penicillin (100U/ml) and strepto-
mycin (100mg/ml). All cells were maintained at 37C
with 5% CO2. Monolayer cultures of A549 cells and
shRNA cell derivatives were used for the interferon
pathway analyses while RD cells were used in all other
experiments.
In silico design of CpG- and UpA-modiﬁed viruses
Two regions of the full-length E7 cDNA pT7:E7 clone
were selected for mutagenesis. These lay in regions of
the genome bounded by the unique restriction sites SalI
(genome position 1878) and HpaI (genome position 3119)
for Region 1 and EcoRI (genome position 5403) and BglII
(genome position 6462) for Region 2. To generate CpG-
zero mutants (designated lowercase ‘c’), all CpG dinucleo-
tides were eliminated by replacement of either the C or the
G base with a randomly alternative selected base selected
to preserve coding of the underlying sequence. A similar
strategy was used to generate UpA-low (designated ‘u’)
and combined zero CpG and low UpA mutants (‘cu’),
with the restriction that UpAp(C or U) codons encoding
tyrosine precluded elimination of all UpA dinucleotides.
Introduction of as many as possible CpG or UpA di-
nucleotides while preserving coding was used to generate
CpG-high and UpA-high sequences (uppercase ‘C’ and
‘U’, respectively). Sequence changes and their effects on
base compositions of the resulting insert sequences are
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shown in Table 1. Sequences generated for the study are
provided in Supplementary Data.
The codon adaptation index for human codon usage
was calculated through the website http://genomes.urv.
es/CAIcal/(9). The Enc (8) and codon pair bias [CPB;
(18,19)] were calculated using the program Composition
Scan in the SSE package (20). The CPB value was
the mean of codon pair scores listed in Supplementary
Table S1 (19) corresponding to each codon pair in the
insert sequences.
RNA structure prediction and sequence variability
Prototype sequences of each species B enterovirus (http://
www.picornaviridae.com/) were scanned for RNA second-
ary structure using the program Folding Energy Scan in
the SSE package using 200 base fragments incrementing
by 152 bases and 50 sequence-order-randomized control
using the algorithm NDR that preserves dinucleotide
frequencies of the native sequence (21). Mean folding
energy difference (MFED) values for each fragment
were plotted against the mid-point of each fragment to
localize areas of sequence-order-dependent RNA second-
ary structure. MFEDs were also similarly calculated
for the reverse complement of each genome sequence.
Synonymous sequence variability was determined by
measurement of mean pairwise distances using the
program Sequence Scan in the SSE package.
Clone construction and recovery of mutant viruses
The full-length E7 cDNA pT7:E7 clone under the control
of a T7 promoter was used for this study. Mutant E7
constructs with altered CpG/UpA content were generated
by ordering custom DNA sequences (GeneArt, Life
Technologies, Paisley, UK). Sequences were provided in
standard antibiotic-resistant cloning vectors and were
cloned into pT7:E7. All clones were sequenced over the
insert regions prior to further applications. To recover the
mutant viruses with altered CpG/UpA content, assembled
plasmids were linearized using NotI and RNA generated
using a Mega Script T7 in vitro transcription kit
(Ambion). 100 ng of RNA was transfected into RD cells
using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. The resulting cell lysates
were used to generate passage 1 stocks by re-infecting
RD cells. Viral titres were determined by TCID50 titration
in RD cells.
Replication phenotype
RD cells were seeded at 5 105 cells per well in six-well
plates and subsequently infected with the wild-type (WT)
or CpG/UpA mutants at an multiplicity of infection
(MOI) of 0.01 per cell for 1 h before removing the
inoculum and washing the cells. Samples were then
withdrawn at given time points (12, 18, 24, 30 and 42 h
post-infection) and the viral titre determined by measure-
ment of TCID50s in 96-well format plates. The assay was
performed in triplicate for each virus. For plaque assays,
conﬂuent RD cells in 100-mm dishes or 6-well plates were
inoculated with virus in DMEM and incubated for 1 h at
37C with occasional rocking. The inoculum was removed
and replaced with an overlay consisting of 2% Methocell
(MC, Sigma) in DMEM. Plates were incubated for 96 h at
37C, ﬁxed with 3.5% formaldehyde and stained with
0.1% crystal violet. Plaque sizes were quantiﬁed using
ImageJ software.
Quantitative real-time polymerase chain reaction
RNA was isolated from cells using the RNAspin Mini Kit
(GE Healthcare) or from viral supernatant using
the QIAamp Viral RNA Mini Kit (Qiagen). Reverse
Table 1. Composition of e7 and luciferase insert sequences
Region Sequence Symbol G+C
content
Total
changes
freqa CpG total
(changeb)
O/E ratioc freq UpA total
(change)
O/E ratiod Codon usage
CAI Enc CP bias
1 Native W 47.6% – 0.041 51 () 0.730 0.050 62 () 0.742 0.685 56.5 0.047
Permuted P 47.6% 142 0.041 51 (0) 0.730 0.050 62 (0) 0.742 0.694 55.8 0.028
CpG-zero c 44.3% 56 0 0 (51) 0 0.057 70 (+8) 0.741 0.693 47.3 0.042
UpA-low u 50.9% 43 0.045 56 (+5) 0.730 0.015 19 (-43) 0.256 0.672 51.9 0.003
Both-low cu 47.5% 102 0 0 (51) 0 0.015 19 (43) 0.227 0.686 43.6 0.083
CpG-high C 56.5% 150 0.146 180 (+129) 1.828 0.042 52 (10) 0.900 0.666 44.3 0.222
UpA-high U 40.9% 119 0.032 38 (12) 0.756 0.139 171 (+109) 1.593 0.726 45.8 0.094
2 Native W 47.1% – 0.018 18 () 0.320 0.047 48 () 0.695 0.743 52.9 0.023
Permuted P 47.6% 109 0.018 18 (0) 0.320 0.047 48 (0) 0.695 0.739 48.8 0.017
CpG-zero c 45.5% 21 0 0 (18) 0 0.047 48 (0) 0.654 0.739 50.1 0.085
UpA-low u 50.0% 34 0.021 21 (+3) 0.331 0.014 14 (34) 0.215 0.781 48.7 0.050
Both-low cu 48.5% 55 0 0 (18) 0 0.037 38 (10) 0.824 0.788 47.1 0.121
CpG-high C 56.4% 124 0.133 135 (+116) 1.667 0.037 38 (10) 0.824 0.658 40.3 0.247
UpA-high U 39.2% 107 0.015 15 (3) 0.390 0.149 151 (+103) 1.633 0.606 39.0 0.048
Luc Native L 45.3% – 0.063 103 () 1.242 0.052 85 () 0.699 0.647 45.0 0.103
Both-low I 43.2% 176 0.006 1 (102) 0.013 0.018 19 (66) 0.145 0.740 0.74 0.118
aFrequency of dinucleotide in insert region.
bTotal number of CpG and UpA dinucleotides in sequence. Changes in numbers between mutated and original WT sequence are indicated in
parentheses.
cRatio of observed dinucleotide frequency (O) to that expected based on mononucleotide composition (E) i.e. f(CpG)/f(C) * f(G).
dO/E ratio based on f(UpA)/f(U) * f(A).
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transcription was performed using M-MLV reverse tran-
scriptase (Promega) and random primers The qPCR reac-
tions were done using Sensifast SYBR Hi-Rox master mix
(Bioline) in a Rotorgene-Q cycler (Qiagen) using the
primers listed in Supplementary Table S1. For E7, a
standard curve using quantiﬁed PCR product was
carried out in parallel, allowing quantiﬁcation of viral
copy number. RNA to infectivity ratio was determined
by viral load measurements of RNA extracted from
5000 TCID50 units of each virus.
siRNA knockdown of PKR
Double stranded RNA-dependent protein kinase (PKR)-
speciﬁc siRNA (EIF2AK2, Ambion Silencer Select
validated siRNA) was used at a concentration of 33 nM.
Transfections were performed using Lipofectamine 2000
(Invitrogen) using 1 ml of lipofectamine per 24 well accord-
ing to the manufacturer’s instructions. Cells were
incubated for 48 h before further experiments were per-
formed. Validated non-targeted control siRNA was used
at the same concentration and incubation period. To
quantify the degree of knockdown of PKR by siRNA,
equal amounts of protein extracted from cell lysates 48 h
after siRNA transfection were blotted and detected
using a PKR-speciﬁc mAB (Ye350, Abcam) followed
by anti-rabbit HRP-conjugated antibodies (SA1-200,
Pierce antibodies) and ECL detection. Band densities
were measured for two independent experiments. PKR
mRNA expression was quantiﬁed at the same time point
by qPCR using PKR-speciﬁc primers.
Replicon construction and replication kinetics
To accurately quantify intracellular viral replication, the
pRiboE7luc sub-genomic replicon plasmid was used. This
contains a version of the E7 genome in which the struc-
tural genes (nucleotides 753–3118) are replaced with the
1704-bp-long ﬁreﬂy luciferase gene. A synthetic version of
the luciferase gene with its CpG and UpA dinucleotides
removed while maintaining its coding sequence was
designed, which also included a CpG- and UpA-low
72-bp linker sequence at the 3’ containing a SanDI restric-
tion site. The sequence was cloned into pT7:E7 using the
unique restriction sites KasI (genome position 781) and
SanDI (position 3191). To create replicons containing
the additional Region 2 CpG or UpA low inserts
(designated ‘lj-jc’ and ‘lj-ju’, with the original clone
designated as ‘Lj-jW’), a 3235-bp section of the replicon
directly downstream of the luciferase gene was excised
using SanDI and BglII restriction enzymes. This was
then replaced with the equivalent sections of the previ-
ously described cjc or uju constructs with their modiﬁed
Region 2 sequences. Replicon plasmids were linearized
using NotI; RNA were synthesized in vitro using T7
RNA polymerase (Ambion); and RNA integrity was con-
ﬁrmed using an 2100 Bioanalyser (Agilent) before use.
Assays were performed by transfecting 50 ng of replicon
RNA into RD cells seeded at 3 104 cells per well in
96-well plates. RNA was transfected at given time points
(1, 4, 6, 8 and 12 h) before luciferase assays were carried
out using the Luciferase Assay System (Promega),
according to the manufacturer’s instructions. Cells were
lysed using the Passive Lysis Buffer, and the cell lysate
was transferred to opaque 96-well plates for luminescence
analysis using the Glomax Multi Detection System
(Promega).
Sequencing of individual virus genomes
Viral RNA was isolated from E7 WT, R1/R2 CpG-high
or R1/R2 UpA-high virus stocks generated in RD cells,
and cDNA created. Nested primers were designed to
amplify a 500-bp section of the modiﬁed Region 1
(nucleotides 1835–2363) and an unmodiﬁed region of
E7 (nucleotides 3241–3723) using primers listed in
Supplementary Table S1 (Supplementary Data). The
proofreading enzyme PfuTurbo DNA Polymerase
(Agilent) was used to amplify the two sections from each
cDNA. The products were puriﬁed, cloned into a TA
vector (pGEM-T easy, Promega) and transformed into
competent E. coli, generating a separate colony for each
copy of the original viral cDNA. The 500-bp inserts were
sequenced using M13 primers.
Competition assays
Equal titres of WT and mutant virus (combined
MOI=0.01) were applied simultaneously to RD cells in
24-well plates. Following CPE, the supernatant was
frozen, thawed and 200 ml applied to fresh RD cells.
This was continued for up to 10 passages, and performed
in triplicate for each virus competition. For the pairwise
competition assay, RD cells were inoculated with paired
combinations of seven viruses, giving 21 combinations in
total. Each pairwise assay was carried out in a single well
and passaged through RD cells 10 times. RNA was
isolated from the ﬁnal supernatants; cDNA was generated
and nested PCR carried out to amplify either Region 1 or
Region 2 using primers listed in Supplementary Table S1.
The ampliﬁed fragment was then subjected to restriction
endonuclease cleavage to estimate the proportion of each
sequence (enzymes listed in Supplementary Table S2).
Early intra-cellular replication kinetics
For synchronized infections, RD cells were infected at 4C
with a total of 2 108 genome copies (1000 per cell) and
maintained at 4C for 30min before being moved to 37C.
Cells were washed twice with PBS and then trypsinized 1 h
or 4 h post infection. The cells were then pelleted and
washed again in PBS before RNA was isolated and viral
copy number determined by qRT-PCR. Copy number was
normalized against the housekeeping gene GAPDH by
qRT-PCR primers (primers listed in Supplementary
Table S1).
Replication of virus with exogenous interferon-b
RD cells in 24-well plates were pre-treated before infection
with 1000U/ml human interferon-b (IFNb) for 24 h, or
mock treated with DMEM. Cells were then infected with
WT or mutant E7 at an MOI of 1 for 1 h before the
inoculum was removed and replaced with media contain-
ing the same concentration of IFNb as previously. Eight
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hours post-infection, RNA was isolated as described
above. Viral copy number was determined by qRT-PCR
as described previously.
Analysis of viral growth following inhibition/knockdown of
signalling pathway components
RD cells in 24-well plates were treated 45min before
infection with 2-aminopurine (2-AP, dissolved in PBS–
glacial acetic acid 200:1) and C16 (dissolved in DMSO)
at ﬁnal concentrations of 5 and 2 mM, respectively. RD
cells were treated 2 h before infection with the cyclin-de-
pendent kinase (cdk) inhibitor, roscovitine (dissolved in
DMSO), at a ﬁnal concentration of 40 mM. All inhibitor
experiments used mock-treated cells with their respective
solvents alone.
Cells were infected with WT or mutant variants of E7 at
MOIs of 0.03–0.1, and viral RNA was isolated from cells
24 h later. Viral load was quantiﬁed using qRT-PCR. Cells
expressing PKR, retinoic acid-inducible gene-I (RIG-I)
or melanoma differentiation associated gene 5 (MDA-5)
shRNA were used to investigate the effect of PKR, RIG-I
or MDA5 knockdown on viral growth. shPKR, shRIG-I
and shMDA5 cell lines, as well as the parental A549 line,
were infected with WT or mutant variants of E7 at an
equal RNA copy number relating to a wild-type MOI of
1. Viral RNA was isolated and quantiﬁed 8 h post
infection.
Innate and adaptive immune responses PCR array
RD cells in 24-well plates were infected with E7 WT or
mutant viruses at an MOI of 10, or a consistent viral
genome copy number equating to an MOI of 10 in the
WT. Sendai virus and Poly I:C, strong inducers of
IFNb, were separately inoculated as positive controls.
Viral RNA titres were conﬁrmed in virus stock preps
using qRT-PCR. Cells were harvested 8 h post infection,
and RNA was isolated. RNA from six biological repli-
cates was combined, and RNA integrity number was con-
ﬁrmed to be greater than 9.7 for all samples using a 2100
Bioanalyzer (Agilent). cDNA was made using the RT2
First Strand cDNA Synthesis kit (Qiagen) with 800 ng
RNA per sample. The relative expression of 84 candidate
genes was then analysed with pre-made ‘Human Innate &
Adaptive Immune Responses PCR Array’ RT2 Proﬁler
PCR Arrays (SABiosciences, catalogue number PAHS-
052), and RT2 SYBR Green Rox Fast Master Mix
(Qiagen). Cycling conditions were 95C for 10min,
followed by 40 cycles of 95C for 15 s and 60C for 30 s.
Data were normalized and fold changes calculated
using the PCR Array Data Analysis Web Portal
(SABiosciences).
RESULTS
Strategy for maximizing or minimizing CpG/UpA content
in mutant viruses
Like other small RNA viruses, the frequency of CpG di-
nucleotides in the E7 genome is suppressed relative to the
expected frequency based on its G+C content, with an
observed to expected ratio of CpG dinucleotides in the
coding sequence of E7 of 0.58. Frequencies of UpA di-
nucleotides are also suppressed in the E7 genome
(observed to expected ratio of 0.78).
To investigate whether CpG and UpA dinucleotide
frequencies inﬂuenced the ability of E7 to replicate
in vitro, we created a series of mutated viruses in which
frequencies of both nucleotides were changed from their
native levels. This was achieved by reverse genetics using
the pT7:E7 infectious clone. RNA transcripts generated
from a linearized plasmid containing the E7 complete
genome sequence generate infectious virus for phenotypic
characterization after transfection into a wide range of
mammalian cells.
To select areas for mutagenesis, we sought to avoid
regions of the genome that contained RNA elements
required for replication or translation functions of the
virus, such as the cis-replicating element (CRE)
embedded in the 2C coding sequence (2). By scanning an
alignment of complete genome sequences of each of the
currently described species B serotypes (including the
pT7:E7 sequence of the infectious clone), an area of
marked suppression of sequence variability co-localized
in the 2C region with the CRE (Figure 1). Calculation
of folding energies to detected RNA secondary structure
in the genome showed prominent regions of structure in
the 5’UTR, 3’UTR and the CRE. MFED values were
consistently higher for species B sequence orientated in
the plus (genomic RNA) orientation. The remainder of
the genome showed no evidence for consistent RNA struc-
ture formation (MFED values around zero) (Figure 1).
The combination of unrestricted synonymous variabil-
ity and an absence of RNA secondary structure over long
stretches of the E7 genome provided opportunities for
altering dinucleotide frequencies without disrupting po-
tential replication elements embedded within the coding
sequence. Two genome regions (occupying positions
1878–3119 and 5403–6462, individually corresponding to
16.7% and 14.2% of the full length genome) were selected
for mutagenesis based on these criteria. Sequences were
modiﬁed by replacing nucleotides within CpG or UpA
dinucleotides with alternative bases that preserved
coding. It was possible to remove all CpG dinucleotides
from both regions and reduce UpA to frequencies ap-
proximately one third of wild-type levels (Table 1; CpG-
zero and UpA-low insert sequences). As an alternative
strategy, to maximize frequencies of these dinucleotides,
every site that could tolerate the creation of these di-
nucleotides without changing coding was identiﬁed and
mutated to create sequences with 2.5–3x their naturally
occurring frequencies (Table 1; CpG-high, UpA-high).
To ensure that sequence disruption did not damage or
destroy undetected replication element(s) within Region
1 and 2, sequences were permuted using the algorithm
CDLR in the SSE sequence package (E7-permuted in
Table 1). This randomizes the order of codons within
the sequence while maintaining coding and dinucleotide
frequencies through swaps between equivalently coding
triplets in the same upstream and downstream dinucleo-
tide contexts. All mutated sequences were then synthesized
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and cloned into the pT7:E7 infectious clone using natur-
ally occurring restriction sites.
Replicative ﬁtness of mutants with modiﬁed
CpG/UpA frequencies
Wild-type E7 and mutant viruses were recovered in cell
culture by transfecting whole-genome RNA sequences
obtained through T7 transcription of pT7:E7. Recovered
virus was then titred by measurement of TCID50 values
and used in subsequent experiments. In the following
sections and associated ﬁgures and tables, wild-type and
permuted control sequences were designated as W and P;
high CpG and UpA mutants as U and C and low mutants
as u and c. Clones in which region 1 was exchanged were
designated as UjW and CjW for UpA and CpG-high
sequences respectively; region 2 as WjU and WjC etc.
RNA copy to infectivity ratios were determined by
extracting viral RNA from a known infectious titre of
each virus, and carrying out qRT-PCR quantiﬁcation
(Figure 2). The RNA to infectivity ratio of the permuted
double region mutant, PjP (247±9.2), was similar to that
of the WT E7 virus, WjW (354±8.0), indicating that the
process of synonymous nucleotide replacement while
preserving native dinucleotide frequencies does not affect
speciﬁc infectivity. In contrast, increasing either the CpG
or UpA dinucleotide frequency dramatically increased the
RNA to infectivity ratio, with values for the CjC mutant
approximately 350 times the WT value and UjU approxi-
mately 20 times higher. In contrast, the RNA to infectivity
ratios of viruses with reduced CpG and UpA frequencies
(cjc, uju and cujcu) were comparable with those of WjW
(Figure 2).
In a multi-step infection using an MOI of 0.01, the
growth kinetics of the E7 mutants were compared with
that of the WT. Increasing the CpG or UpA dinucleotide
frequency caused a severe attenuation of viral replication,
resulting in a viral output approximately 7000-fold lower
in CjC than WjW after 24 h, and a 30-fold lower output in
UjU (Figure 3A andC). Mutant viruses replicated more
slowly as well as producing a lower ﬁnal output of infec-
tious particles. Increasing dinucleotide frequencies in
Region 2 was more detrimental to viral replication than
Region 1, despite its shorter length (1 kb compared with
1.3 kb), with CjW mutants replicating only 144-fold less
than wild type at 24 h, compared to nearly 1500-fold less
in WjC. Amongst the UpA-high mutants, replication was
actually improved by modifying R1, with UjW consist-
ently showing 10-fold greater replication than wild type
while the R2 mutant replicated similarly to UjU.
Replication of the (CDLR–)permuted control (PjP) was
indistinguishable from wild type, conﬁrming that there
were no critical cis-acting replication elements within the
modiﬁed regions. A similar but less marked pattern of
replication differences was observed in a single-step repli-
cation assay where cells were infected at an MOI of 10 at
time zero, including enhanced replication of the UjW
mutant (Supplementary Figure S1A).
Mutants with reduced CpG and UpA dinucleotide
frequencies compared with the WT level accelerated viral
replication (Figure 3B andD). While replication rates and
Figure 1. Genome organization of E7 and positions of mutated insert regions. Insert positions are compared with genome diagram and a plot of
sequence variability within species B enteroviruses at synonymous sites (blue line) and folding energies indicative of RNA secondary structure (red
and pink lines). Variability at synonymous sites (left y-axis) was computed at each codon position in alignments, plotted with a window size of 41
codons. MFED values (right y-axis) for sense and antisense RNA sequences were calculated for 200 base fragments, incrementing by 48 bases; values
plotted represent mean values of ﬁve consecutive fragments. Nucleotide positions were calculated relative to the pT7:E7 cDNA sequence.
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ﬁnal viral outputs of the CpG-zero (cjc) and UpA-low
(uju) mutants were similar to wild-type and permuted
controls, the double mutant in which both CpG and
UpA were reduced or eliminated (cujcu) showed 10-fold
higher yield than the wild type at both 18 and 24 h post in-
fection. Replication differences were again less marked in
the less-sensitive single-step assay, with similar replication
curves between low mutants and controls (Supplementary
Figure S1B).
Altering CpG and UpA dinucleotide frequencies also
inﬂuenced plaque sizes of individual infectious centres
created in RD cell monolayers (Figure 4). R1/R2 CpG
high and UpA high mutants showed plaques that were
respectively 48% (SEM±5%) and 43% (± 6%) the
size of WT plaques. Areas of UpA- and CpG-low
mutants were conversely consistently greater than WT
(mean values for cjc: 144% (± 19%); uju: 129%
(± 16%) and cujcu: 179% (± 17%) of WT size). In
contrast, plaques produced by the permuted control,
PjP, were indistinguishable to those of WT (98±13%).
To determine whether the low RNA/infectivity ratios
and reduced replication of CpG- and UpA-high mutants
was the result of their failure to initiate an infection cycle
or whether there were later restrictions on the generation
of infectious virions, RNA copy numbers immediately
post-entry were compared with those 4 h after infection.
One hour after a synchronous infection with 1000 RNA
copies per cell (as determined by qRT-PCR), the number
of intracellular viral genome copies was found to be
similar between viruses with different dinucleotide com-
positions, with 42, 19 and 36 RNA copies detected per
cell in those infected with WT, CjC and UjU mutants,
respectively (Figure 5). However, 4 h post infection,
RNA copy numbers of wild-type genome copies increased
to 2362 per cell, whilst the RNA copy numbers of CjC and
UjU mutants only increased marginally (58 and 207 RNA
copies per cell, respectively). The existence of this early
impairment has implications in subsequent pathway
analyses (see below).
To further investigate the enhancement of replication
observed in E7 variants with reduced CpG and UpA
frequencies, the effect of dinucleotide changes on the rep-
lication of an E7 replicon was investigated. The E7
replicon comprises a monocistronic construct in which
structural genes are replaced by a luciferase gene derived
from the ﬁreﬂy (Photinus pyralis); detection of lumines-
cence enables genome replication to be readily detected
and quantiﬁed. The luciferase gene in the pRiboE7luc
1.7 kb luciferase gene revealed a strikingly high frequency
of CpG (ratio of 1.24; Table 1), consistent with its insect
origin (20,22,23). This could potentially attenuate its rep-
lication in mammalian cell lines. A replacement luciferase
gene was therefore designed in which the CpG ratio was
reduced to 0.013 and the UpA ratio to 0.145 (from 0.699),
in both cases the lowest values achievable without coding/
restriction enzyme site changes, through introduction of
synonymous substitutions. The CpG/UpA-low luciferase
replicon (designated cuj-jW) was further modiﬁed by
replacing region 2 with CpG-zero and UpA-low inserts
(designated cuj-jc and cuj-ju respectively; the site of
Region 1 was occupied by the luciferase gene and
indicated as a ‘’).
RNA transcripts were transfected into RD cells, and
luminescence was monitored over a 12-h time-course
(Figure 6). Compared with the original pRiboE7luc
replicon, the cuj-jW mutant with the luciferase gene
replaced showed a 100-fold increase in relative lumines-
cence as early as 4 h post transfection. The replication of
the construct was increased a further 6-fold by replace-
ment of Region 2 with CpG-zero or UpA-low inserts.
Fitness comparisons of modiﬁed viruses using
competition assays
To conﬁrm the differences in replicative ability of mutants
with altered CpG and UpA frequencies in a more sensitive
assay, equal MOIs of WT and mutants were co-inoculated
onto RD cells and serially passaged at high MOIs between
passages. RNA extracted at different passage numbers
was ampliﬁed across the modiﬁed region and cleaved
with restriction enzymes that differentiated WT from
mutant sequences. As expected, CpG- and UpA-high
mutants (CjC and UjU) were rapidly outcompeted by
WT virus and were almost eliminated by passage 1,
and entirely undetectable at passage 5 (data not shown).
Single region mutants (CjW and WjC) were similarly
outcompeted by passage 5, consistent with their reduced
Figure 2. RNA to infectivity ratios of WT and viruses with modiﬁed
CpG/UpA frequencies. WT and mutant viruses were recovered from
RD cells and TCID50 titres determined (note log scale). The number of
viral genome copies was determined through qRT-PCR and compared
with the infectivity titre. Results are the mean and standard error from
three separate extractions. RNA/infectivity ratios were additionally
calculated for CjC and UjU mutants in the presence of C16.
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ﬁtness in the replication assays (Figure 3A and
SupplementaryFigure S1A). Reﬂecting the more
marginal phenotype of UpA-high mutants, WjU was
eliminated between passage 5 and 10 while UjW
outcompeted the wild-type virus by passage 10 (Figure
7). This latter ﬁnding conﬁrms evidence for greater repli-
cation of this mutant compared with WT in multi- and
single-step replication assays.
The same assay format was used to further characterize
the unexpected greater replicative ability of E7 mutants
with reduced CpG and UpA frequencies; cjc and uju
mutants both outcompeted WT showing at least 80%
prevalence after only ﬁve passages. By 15 passages, the
WT was completely undetectable (data not shown). To
investigate this phenomenon further, a series of competi-
tion assays were performed in which WT (WjW), the
permuted control (PjP) and a range of mutants with dif-
fering degrees of CpG and/or UpA underrepresented
(cujW, Wjcu, uju, cjc and cujcu) were each competed
with each other and assayed at passage 6 and 10
(Figure 8). The cujcu mutant showed the highest ﬁtness,
completely outcompeting almost all of the other viruses by
passage 6. The cjc mutant ranked second, followed
by cujW. Lowering CpG/UpA frequency in Region 1
Figure 3. Replication kinetics and titres at 24 h of WT and modiﬁed viruses infected at a low MOI. RD cells were infected with E7 WT, permuted
(PjP), CpG- and UpA-high mutants (CjC and UjU; A and C) or CpG- and UpA-low mutants (cjc, uju, cujcu; B and D) viruses at an MOI of 0.01.
Infectious titre of supernatants was quantiﬁed at indicated time points by TCID50 (A and B) and mean titres and SEMs at 24 h. Results are the mean
of three biological replicates.
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was demonstrated to have more effect than in R2, as Wjcu
was rapidly outcompeted by cujW as well as
uju. Consistent with the replication assays, reduction
in CpG frequency showed a greater effect than that
of UpA.
Mechanism of dinucleotide-dependent replicative
ﬁtness differences
The pathway(s) within the cell responsible for the replica-
tion phenotypes of viruses with different dinucleotide
frequencies is unknown. Investigation of pathways
concentrated primarily on measurement of differences
between replication between WT and CjC and UjU
(high) mutants, as these showed the greatest phenotypic
differences in replication assays. Secondly, WT E7
replicated rapidly to high titre in ﬁbroblast cell culture
and was evidently highly effective at evading host re-
sponses induced by infection. As described below, effective
control in many aspects of both recognition and effector
pathways precluded detection of phenotypic differences
from CpG/UpA low mutants.
Replication differences between WT and mutant with
altered dinucleotide frequencies may arise through differ-
ences in their susceptibility to IFNb-coupled cellular
defences or through differences in their visibility to
pattern recognition receptors (PRRs) that activate the
cellular defence response on entry. To investigate the
former possibility, susceptibilities of WT and mutant
viruses to exogenous IFNb were determined (Figure 9).
Eight hours after infection, WT and mutant viruses
showed dose-dependent attenuation of replication, with
between 8- to 27-fold reductions in viral RNA levels
relative to the mock-treated controls at the highest IFNb
dose. While generally similar to WT virus, the replication
of both CjC and UjU (high) mutants showed approxi-
mately 2-fold greater susceptibility to IFNb than WT
while the CpG/UpA-low mutant showed approximately
2-fold greater resistance. However, these differences do
not account for the 100- to 10 000-fold impairments and
Figure 5. Synchronized infection with equal viral genome copies. RD
cells were synchronously infected with 1000 genome copies of WT, R1/
R2 CpG-high or R1/R2 UpA-high virus, as calculated using qRT-PCR.
Cells were trypsinized and washed 1 or 4 h post infection and the intra-
cellular viral load determined by qRT-PCR. Results are the mean and
standard error of three biological replicates.
Figure 4. Plaque morphology of E7 WT and double region mutant
viruses. RD cell monolayers in 10-cm plates were infected with a
similar infectious titre of virus and incubated for 96 h at 37C.
(A) Plaque appearance. (B) Plaques sizes of WT and mutant E7
viruses calculated from 25 plaques for each virus using ImageJ
software (mean values and SEMs relative to WT control shown as
bar heights and error bars).
Figure 6. Analysis of luciferase expression driven by E7 replicons with
reduced CpG/UpA frequencies. Replicons were generated with reduced
CpG/UpA frequencies, based on the backbone pRiboE7luc replicon, in
which the structural genes of E7 are replaced by an insect luciferase
gene. In the cuj-jW replicon the luciferase gene itself was modiﬁed to
minimize both CpG and UpA frequency; in the cuj-jc and cuj-ju rep-
licons Region 2 was additionally modiﬁed to further reduce either CpG
or UpA frequency. RNA was generated from replicons and trans-
fected into RD cells. Luminescence was measured relative to the
mock-transfected control. Results are the mean and standard error of
three biological replicates.
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10-fold enhancements in replication respectively observed
for these mutants (Figure 3).
A second possibility to explain replication phenotypes is
that dinucleotide frequencies inﬂuence the susceptibility of
viruses to RNA editing by the IFNb-induced p150 isoform
of adenosine deaminase RNA-speciﬁc (ADAR1) (24). A
greater number of mutations in genomes of CpG- and
UpA-high E7 mutants might therefore account for their
greatly induced RNA to infectivity ratios (Figure 2). To
investigate this, two 500 base regions of the wild type, CjC
and UjU mutants were sequenced. Sequences from either
the modiﬁed Region 1 (nucleotides 1835–2363) or an un-
modiﬁed region (nucleotides 3723–3241) were ampliﬁed
and individual population components sequenced by
cloning the PCR product and sequencing individual
clones. At least 14 clones were sequenced in each region
for each virus (Supplementary Table S3). In wild-type E7,
no mutations were observed in the total 15.5 kb
sequenced. In the CjC virus, three synonymous single-nu-
cleotide changes were observed in the total 15 kb
sequenced, while in UjU a total of 15.5 kb revealed one
synonymous change and one U!C substitution, convert-
ing a methionine residue into a threonine. Although the
amount of sequence data obtained was limited, the pre-
dominantly synonymous mutations observed in CjC and
Figure 7. Fitness determination by competition assays between WT
and modiﬁed viruses. RD cells were infected with an equal MOI of
WT and modiﬁed virus, and the supernatant serially passaged through
cells. RNA was isolated and the composition of each virus determined
through selective restriction digests. Images show the virus composition
in the starting inoculum and in three biological replicates following
passage of CpG- and UpA-low mutants and of UjW.
Figure 8. Pairwise ﬁtness comparison between E7 WT and mutant with
varying degrees of CpG and/or UpA under-representation. RD cells
were infected with an equal MOI of two viruses represented in
columns and rows of the matrix and the supernatant serially
passaged. The composition of each virus was determined through re-
striction endonuclease cleavage (see Figure 7) and outcome displayed
by colour shading. The key refers to population representations of
viruses listed in columns (for example, all but one variants were out-
competed by the cujcu mutant). The ﬁtness ranking deduced from these
results is shown underneath the ﬁgure.
Figure 9. Effect of exogenous IFN-b on viral replication. RD cells
were treated with 5, 50 and 500U/ml human IFN-b, or mock
treated, then infected with WT E7, CjC, UjU and cujcu mutants at
an MOI of 1. RNA was isolated after 8 h and viral load determined by
qRT-PCR. Results are the mean and standard error of two biological
replicates.
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UjU mutants do not suggest any substantially greater sus-
ceptibility to ADAR1-mediated mutation, and this would
be unlikely to be responsible for their dramatically
impaired replication.
Another possibility for the different phenotypes of E7
dinucleotide mutants is that they differentially activate the
IFNb response in infected cells. To investigate the cellular
response to infection, the expression of 90 innate immune
response genes was analysed following infection with E7,
CjC or UjU viruses. WT E7 induced a minimal IFNb
response at 8 h with transcript levels at the limit of detec-
tion, a similarly unaltered level of the early interferon-
stimulated genes (ISGs) 15 and 56, and small changes in
expression of a total of six genes from the 90 immune
response genes (Figure 10 and Supplementary Figure
S2). Of these, ﬁve were up-regulated 2- to 5-fold and one
was down-regulated. The response was quantitatively and
qualitatively much weaker than in cells transfected with
poly-I:C or infected with Sendai virus (Figure 10), where
there were large increases in the expression of IFN-b and a
range of other innate response genes.
Similarly, inoculating cells with infectious doses of CjC
and UjU mutants equivalent in RNA copy number to
those of WjW (i.e. MOIs 100- to 1000-fold lower than
WT) induced no IFNb or ISG responses and minimal
changes in gene expression of other genes in the
PCR array (>2- and <5-fold induction of three and
four genes, respectively; Figure 10 and Supplementary
Figure S3). This demonstrated that RNA genomes with
increased dinucleotide frequencies entering the cell equiva-
lently to WT (see above) activated only a minimal cellular
response. However, infecting cells with UjU and particu-
larly CjC mutants at equal MOI to WT induced a higher
IFNb response, which was also reﬂected by a greater
number of changes in gene expression in the PCR array.
Infecting with the CjC mutants led to 12 genes being
up-regulated (and 5 down-regulated).
To investigate potential signalling pathways that were
differentially activated by viruses with differing dinucleo-
tide frequencies, the replication of E7 and mutant viruses
(CjC and UjU) was measured in cells in which expression
of speciﬁc signalling component was inhibited. Interferon
regulatory factor 3 (IRF3) is a central regulator of type I
IFN induction in response to the detection of viral RNA
in the cytoplasm or endosomes, and its signalling is
blocked by the viral Npro protein from classical swine
fever virus (25). Both mutant and WT viruses inoculated
at equal MOIs replicated to higher levels in cells express-
ing Npro compared with the parental A549 cell line, with 8-
fold increases in WT virus and 3- to 4-fold in CjC and
UjU (Figure 11). Replication of E7 is therefore at least
partially controlled through activation of the IRF3
signalling pathway even though IFNb and other cellular
responses are highly restricted. However, there was no
evidence that IRF3-signalled inhibition of virus replica-
tion was differentially activated by mutants with
elevated CpG and UpA dinucleotide frequencies; fold in-
creases in replication were actually less than those dis-
played by WT E7.
IRF3 is part of a signalling pathway that is activated
upstream by the cytoplasmic dsRNA sensors RIG-I and
MDA5. Another PRR that is potentially responsible for
differential recognition of infecting viruses with differing
dinucleotide compositions is PKR. To investigate their
roles in recognition, replication of WjW, UjU and CjC
mutants was determined in A549 cells expressing
shRNAs targeting each PRR (Supplementary FigureS3).
Down-regulation of RIG-1 had no effect on the replica-
tion of WT or mutant E7 variants, while the replication of
CjC and UjU mutants (but not WT E7) was marginally
increased (2-fold) in cells expressing the MDA-5 shRNA
(Figure 12A). In contrast, down-regulation of PKR had a
partial inhibitory effect on the replication of WT and UjU
mutant E7 variants, but little or no inﬂuence on CjC
mutant replication.
We investigated this latter observation further by in-
hibiting PKR expression in RD cells by transfecting
them with a PKR-speciﬁc siRNA to PKR. These down-
regulated PKR mRNA and protein expression by
>80%, irrespective of whether infected by E7 or not
(Supplementary Figure S4). Under these conditions, the
replication of WT and CjC, UjU mutants was consistently
reduced compared with that in cells pre-treated with the
control siRNA as was the replication of the cujcu mutant,
which we additionally tested (Figure 12B).
Although speciﬁc knockdown of PKR expression by
shRNA and siRNA typically inhibited replication of
E7 and its mutants, treatment of cells with the kinase in-
hibitor C16 dramatically enhanced virus replication of
mutants with increased frequencies of CpG and UpA di-
nucleotides (Figures 13 and 14). Treatment of cells with
C16 led to 10- to 100-fold increased in the replication
of CjC and UjU mutants, while the replication of WT
and cujcu (CpG/UpA-low) mutants was relatively un-
affected (Figure 13). We extended this study to determine
the cytopathology of selected mutants. Infecting cells with
WT virus at an MOIs of 0.1 produced visible pathology
after 22 h, and limited cytolysis at an MOI of 0.01
(Figure 14A). This was unaffected by the addition of
C16. In marked contrast, untreated cells infected with
CjC and UjU mutants showed no cytopathology over
the experimental interval while those treated with C16
showed complete CPE at an MOI of 0.01. C16 treatment
similarly increased the infectivity of CjC and UjU mutants
(Figure 14B). Virus stocks containing 3000 PFU/ml, as
measured previously on untreated RD cells, were re-
titrated in a quantal infectivity assay with six replicated
at serial 10-fold dilutions and infectious titres determined
by probit analysis. C16 treatment had no effect on the
infectivity of WT or cujcu E7 variants, while infectivity
was enhanced 10-fold (UjU) and nearly 1000-fold (CjC)
in mutants with increased dinucleotide frequencies
(Figure 14B). Using these revised infectivity titres, CjC
and UjU mutants showed equivalent RNA/infectivity
ratios to WT virus in the presence of C16 (Figure 2).
The attenuating effect of increased CpG and UpA
frequencies on E7 replication is thus entirely reversible
by C16; the reduced infectivity of high CpG/UpA
mutant stocks is clearly not because the virus is intrinsic-
ally defective but because the cell is better able to prevent
infection by these mutants than by WT virus.
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Although C16 has been considered to be a speciﬁc in-
hibitor of PKR (26), its effect on the replication of GpG-
and UpA-high mutants was inconsistent with the lack of
similar replication enhancement using sh- and siRNAs
directed against PKR mRNA (Figure 12). The possibility
of an off-target effect of C16 was further suggested by the
lack of an equivalent affect on the replication of CjC and
UjU mutants by 2-AP that also inhibits PKR phosphor-
ylation (Figure 13). Documented additional targets of C16
include the cyclin-dependent kinases, CDK2 and CDK5
(27). To investigate whether these unintended actions of
C16 were inﬂuencing E7 replication, we determined the
effect of a well characterized inhibitor of cyclin kinases,
roscovitine, on the replication of WT and mutant variants.
Cells infected with WT and cujcu E7 variants showed
nearly 10-fold reduced E7 replication compared with un-
treated cells while the replication of UjU replication was
unchanged and CjC substantially enhanced (&9-fold). As
observed with C16 treatment, roscovitine induced visible
cytopathology in CjC-infected cells while none was
apparent in controls (data not shown). Increased CjC rep-
lication occurred despite a general reduction in cellular
gene expression in treated cells (including a 3-fold reduc-
tion in the housekeeping gene, GAPDH).
DISCUSSION
Although decreases in virus ﬁtness and replication by
increasing CpG and UpA frequencies in RNA virus
genomes has previously been described for poliovirus,
this study is the ﬁrst to demonstrate the converse, that
decreasing frequencies of these dinucleotides signiﬁcantly
increases virus replication. This remarkable ﬁnding raises
profound questions about the nature and direction of evo-
lutionary selection operating in enteroviruses and poten-
tially each of the many other RNA viruses that show
similarly suppressed CpG and UpA frequencies (10–12).
The study additionally demonstrates that while E7, along
with other enteroviruses, is highly effective at suppressing
IFNb induction and activation of host cell defences, cells
are nevertheless able to recognize and restrict replication
of mutants with differing dinucleotide frequencies. The
ﬁndings point towards a novel mechanism for recognizing
foreign RNA that prevents establishment of virus replica-
tion at an early time point after virus entry.
Relationship between virus replication and CpG and
UpA frequencies
Increasing the frequency of CpG or UpA dinucleotides in
E7 resulted in severe viral attenuation, characterized by
reductions in replication rate, smaller plaque areas, low
particle to infectivity ratio and a low competitive ﬁtness
relative to WT E7. These ﬁndings are consistent with
replication defects observed in poliovirus with elevated
CpG and UpA frequencies in the capsid gene (17,28,29).
The 2009 study by Burns et al. provided a convincing
demonstration that the previously reported attenuating
effect achieved by codon de-optimization (28) was second-
ary and proportional to increases in CpG and UpA
frequencies rather than a slowing of virus replication by in-
efﬁcient translation. Moreover, it was shown that changes
in the capsid to conventional measures of translation efﬁ-
ciency (CAI, Enc, CPB) correlated poorly if at all with
replication rate, in contrast to direct correlations with
changes in CpG and UpA dinucleotide frequencies.
Construction of mutants that increased bias towards
unfavourable codon pairs (19) were remarkably effective
at reducing poliovirus replication but again these also
substantially increased CpG and UpA dinucleotide
frequencies. In their study, however, the PV-Min mutant
contained an observed to expected frequency of CpG of
1.34 (compared with 0.63 of the WT sequence) and 1.36
for UpA (WT: 0.74) that might similarly account for the
observed differences in replication phenotypes rather than
translation effects. These indeed approach levels in the
CpG-high and UpA mutants constructed in the current
study (Table 1). Contrastingly, their attenuation was in-
consistent with the modest 50–70% measured reductions
in translation efﬁciencies of the PV-MinXY and PV-MinZ
mutants. Indeed, the failure to recover any infectious
virus from the whole capsid mutant, PV-Min seems in-
compatible with a measured 25% translation efﬁciency.
A previous study in which translation efﬁciency of polio-
virus 5’UTR mutants was reduced to 12–23% of WT
levels showed an approximately proportionate (1–1.5
log) reduction in replication kinetics (30), quite different
from the replication impairment observed in PV-MinXY,
PV-MinZ and PV-Min. Together, these ﬁndings concur
with the evident lack of correlation between CAI, Enc
and CPB values in the E7 insert sequences (Table 1) and
their replication phenotypes when inserted into E7.
Figure 11. Replication of WT and dinucleotide-modiﬁed viruses in an
IRF3-blocked cell line. A549 cells expressing the viral protein Npro and
non-expressing control cells were infected with WT, CjC (R1/R2 CpG-
high) and UjU (R1/R2 UpA-high) at an MOI of 0.01. RNA was ex-
tracted from cell culture supernatant at 24 h and viral load determined
by qRT-PCR. Results are the mean and standard error of three biolo-
gical replicates.
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As examples, CAI values for CpG-zero sequences were
almost identical to WT E7 while their insertion
enhanced replication. CpG- and UpA-high sequences
actually had higher CAI values yet showed an impaired
replication phenotype. There was a similar lack of associ-
ation with Enc and CPB measures and phenotype.
Our ﬁndings imply a fundamental role of dinucleotides
in replication ability of enteroviruses and potentially other
RNA viruses that show evidence for suppression of CpG
and UpA frequencies. We would argue that their pheno-
typic effects have to be included and allowed for in viral
evolutionary studies such as those measuring often subtle
effects of codon usage or codon order on virus replication.
A case in point relates the concept of evolutionary ‘robust-
ness’ of RNA viruses, based on the hypothesis that the
evolutionary ﬁtness of viral populations is dependent on
shape of the ﬁtness landscape around a consensus wild-
type master sequence (31–33). A recent investigation
of the effect of different ﬁtness landscapes compared
WT poliovirus with two mutants in which codon order,
but not usage, was altered (34). These were constructed
using capsid region sequences in which codon pair
frequencies were skewed towards those most favoured in
human coding sequences (PV-Max) and one where codon
order was randomly permuted while retaining CPB
(PV-SD). Importantly these had the same CAI and Enc
values to WT sequences (and in the case of SD, an iden-
tical CPB); both showed equivalent translation efﬁciencies
in in vitro translation assays.
As expected from their different positions in ‘sequence
space’, the mutants showed different mutational spectra
on passaging with Ribavirin. However what was unex-
pected was their replication phenotypes, with PV-SD
showing lower ﬁtness but PV-Max greater ﬁtness in com-
petition assays with WT. The behaviour of PV-Max is
particularly intriguing as, in common with PV-SD, there
were hundreds of sequences changes from the WT
sequence and likely far from an optimal ‘robustness’ as
conceptualized in the study. We suggest a contributory
factor or alternative explanation for the replication pheno-
types was the unintended alteration of dinucleotide
frequencies in the mutant sequences consequent to permu-
tation of codon order. The PV-SD mutant (unlike CDLR
in the current study) showed increased CpG and UpA
frequencies from 0.60> 0 88 and 0.8>0.91 respectively,
changes that are consistent with its observed modest
ﬁtness defect in competition against WT and lag in
replication kinetics. Conversely, optimization for CP
Figure 12. Effect of inhibiting PKR, RIG-I and MDA-5 expression on E7 replication. (A) Comparison of virus replication in control A549 cells at
8 h compared with that in cells expressing shRNAs targeting PKR, RIG-I and MDA-5 (reduction in mRNA levels achieved is shown in
Supplementary Figure S3). (B) RD cells were pre-treated for 24 h with an siRNA directed against PKR and infected with WT virus or CpG-
high, UpA-high or CPg/UpA-low mutants at an MOI of 0.03. RNA was isolated after 22 h and intracellular viral loads determined by qRT-PCR.
Results are shown relative to the replication rate in cells treated with a control (validated non-target) siRNA.
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frequencies in PV-Max contrived to decrease CpG and
UpA frequencies to 0.40 and 0.60 and which potentially
account for its slight ﬁtness advantage over WT in com-
petition assays, although to a proportionately lesser extent
than the cujW and cujcu E7 mutants in the current study.
Our study additionally provides direct evidence against
the hypothesis for robustness. The E7 codon permuted
sequences (PjP) generated by the CDLR algorithm in
the current study showed 251 sequence differences from
WT yet preserved the exact dinucleotide frequencies of the
WT sequence. Although clearly also residing in a quite
different ‘sequence space’, it showed identical replication
ﬁtness to WT, being present in equimolar amounts to WT
even after 10 passages in a competition assay format
(Figure 7).
Competition assays with WT E7 and a range of CpG-
or UpA-low mutants in regions 1 and 2 showed a close
correlation between ﬁtness and numbers of CpG and UpA
dinucleotides removed (Figure 8). The proposed ﬁtness
ranking additionally demonstrates that both dinucleotides
participate in the ﬁtness enhancement. Removal of CpG/
UpA dinucleotides in Region1 had a greater ﬁtness effect
than Region 2. This likely reﬂects natural compositional
differences between the two regions; the region 1 WT
sequence showed a observed/expected CpG frequency of
0.73, over twice that of Region 2 (0.32). From the ﬁrst
region, 56 CpG dinucleotides were removed to generate
the CpG-zero mutant, over twice that of Region 2
(n=21). Compositional differences also explain why
Region 2 CpG-high mutants showed greater ﬁtness reduc-
tions that Region 1, as CpGs are already over-represented
in the latter part of the genome.
As a possible contributory factor to the otherwise un-
explained greater replication of UjW compared with WT
(Figure 3A andC), generating this mutant led to 12 CpG
dinucleotides being removed from Region 1 (Table 1).
Based on current understanding from the phenotypes of
other mutants, this seems insufﬁcient to fully account for
the ﬁtness gain. However, we know little about whether
speciﬁc thresholds for dinucleotide removal exist; speciﬁc-
ally, are ﬁtness gains associated strictly proportional to the
Figure 14. Inﬂuence of the PKR inhibitor E7 cytopathology and in-
fectivity. (A) Cytopathology of WT, CjC and UjU mutants in RD cells
infected at MOIs of 0.1 and 0.01 in 2mM C16 or untreated control.
Monolayers of untreated cells remain intact on infection with CjC and
UjU mutants while those treated with C16 display a complete CPE
even at low MOI. (B) Infectivity determination of pre-titred virus
stock supernatant (3000 PFU/ml) of WT virus or CpG-high, UpA-
high or CPg/UpA-low mutants in the presence of C16. The enhanced
infectivity of CjC and UjU mutants restored the RNA/infectivity ratios
to those of WT virus (Figure 2).
Figure 13. Effect of the kinase inhibitors, C16, 2-AP and Roscovitine
on E7 replication. Cells were pre-treated for 45min with 2 mM C16,
5mM 2-AP or 40 mM Roscovitine and infected with WT virus or CpG-
high, UpA-high or CpG/UpA-low mutants at an MOI of 0.1. RNA
was isolated at 24 h, and intracellular viral loads were determined by
qRT-PCR. Results are shown relative to the replication rate in cells
untreated cells (note log scale).
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number of CpG and UpA dinucleotides removed, or could
relatively small reductions in frequency display the full
phenotypic effect? As a broader question that relates to
thresholds, does removing (or adding) CpG and UpA di-
nucleotides in two 1000- to 1200-nt regions have the same
effect on replication as adding/removing the same number
over the whole genome. Whether extending the region of
dinucleotide removal to the rest of the genome (excluding
critical replication determinants) would lead to further
proportionate increases in replication is similarly uncer-
tain and is an obvious priority in further studies.
Until we know more about the sequence motifs respon-
sible for the differential recognition of sequences of differ-
ent dinucleotide frequencies, these questions will remain
unresolved. However, the existence of thresholds can be
determined through ﬁtness determination of mutants with
differing degrees of CpG or UpA removal. These investi-
gations are currently planned and will necessitate a more
sophisticated mutagenesis algorithm that introduces add-
itional mutations to compensate for those introduced to
add or remove targeted dinucleotides. The method can
maintain exact mononucleotide frequencies and protein
coding and, to the greatest allowable extent, frequencies
of non-targeted dinucleotides.
Finally, changes in CpG frequency showed a greater
effect on viral replication than changes in UpA levels,
being both more beneﬁcial to replication when lowered,
and more detrimental when raised. When competed
directly, the double region CpG-low mutants were ﬁtter
than their UpA-low mutant counterparts. These ﬁndings
are consistent with those in poliovirus where CpG-high
mutants also exhibited a more severe attenuation than
UpA-high mutants (17); selection to remove CpG di-
nucleotides was similarly substantially greater than
against UpA during serial passage of mutated viruses
(28). Indeed, dissimilar patterns of CpG and UpA sup-
pression amongst viruses and host genomes (10,11,31)
point to different selective pressures acting upon each
dinucleotide.
Irrespective of the underlying mechanism by which
removal of CpG and UpA enhances RNA virus replica-
tion, the ﬁndings may potentially be exploited for
enhancing replication of viruses or other genomes
recovered by reverse genetics for research, therapeutic,
vaccine or other purposes. Changes in the luciferase
gene alone enhanced reporter gene expression in the E7
replicon by >10-fold even though constructs of this type
containing luciferase and other reporter with similarly
elevated CpG frequencies have been in use for many
years without any idea that their replication or reporter
gene expression was potentially suppressed. High CpG
frequencies may similarly limit the expression of trans-
genes and DNA vaccines (35); as with codon pair manipu-
lation, the observed enhancement of expression of
mammalian ‘codon-optimized’ versions of reporter gene
derived from non-vertebrates may indeed be secondary
to reductions in CpG frequencies. Finally, large scale
removal of CpG and UpA dinucleotides from viruses
used as seed stocks for inactivated virus production
(including inﬂuenza A and B viruses and poliovirus)
may increase cell or egg culture virus yields substantially.
Experimental investigation of green ﬂuorescent protein
transgene expression in mouse embryos and of inﬂuenza
production in cell and egg culture using synthetic se-
quences in which CpG and UpA have been largely
eliminated from coding sequences is currently underway.
Mechanism of CpG and UpA recognition
In common with other RNA viruses infecting mammals
and birds, enteroviruses and other picornaviruses have
evolved numerous strategies to evade the antiviral effect
of the innate host response to infection. The effectiveness
of E7 in blocking these cellular response pathways is
attested by the virtual absence of IFNb mRNA synthesis
on infection with high MOIs of WT virus and the minimal
up-regulation of other innate immune response genes
(Figure 10 and Supplementary Figure S2). Evasion
strategies likely resemble those of other enteroviruses
that are known to deploy a range of signalling blocks
mediated through proteolytic cleavage or inhibition of
signalling by RIG-I, MDA-5, TIR-domain-containing
adapter-inducing interferon-b (TRIF), mitochondrial
antiviral signaling protein (MAVS) and the IFNb
receptor, IFNAR1 (36–39), typically by the virally
encoded proteinases 2A and 3C. The enterovirus 2A pro-
teinase additionally cleaves the translation initiation
factor, eIF4G and turns off cap-dependent translation of
cellular mRNAs (40). These strategies exert a powerful
blunting effect on innate as well as acquired immune re-
sponses in the host, as exempliﬁed in hepatitis A virus
through cleavage of both TRIF and MAVS and preven-
tion of both TLR- and cytoplasmic PRR signalling (41).
Because E7 effectively paralyses IFNb-coupled cellular
responses in infected cells, it is most unlikely that the dif-
ferential replication ability of E7 mutants with altered di-
nucleotide frequencies is mediated through differences
in susceptibility to IFNb-coupled defence pathways.
Observationally both WT and CpG- and UpA-high
mutants were similarly susceptible to exogenously added
IFN (Figure 9) and E7 mutants showed little evidence for
greater RNA editing by the IFNb-activated p150 isoform
of ADAR-1 (24) that might otherwise have potentially
accounted for their marked differences in RNA/infectivity
ratios (Figure 2). The restoration of speciﬁc infectivity of
CjC and UjU variants by C16 to WT levels (Figure 2)
indeed demonstrates that these mutant viruses are not in-
trinsically defective.
Differences in viral ﬁtness are therefore likely to arise
due to differential activation of the host innate immune
system, a hypothesis supported by the observation of
almost complete attenuation of replication very early
after infection of RD cells with CjC and UjU mutants.
These were able to enter cells within an hour but subse-
quently either failed to initiate replication or showed dra-
matically reduced genome ampliﬁcation compared to WT
E7 (Figure 5). Candidate PRRs that conventionally rec-
ognise infection by RNA viruses include RIG-I and
MDA5 although ascribing a protective role against E7 is
problematic. For the former, recognition requires RNA
sequences containing 5’ triphosphate groups while
MDA5 requires long dsRNA sequences created during
16 Nucleic Acids Research, 2014
 by guest on January 31, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
virus replication (42–44); neither of these PAMPs are
present immediately after virus entry. Furthermore, their
signalling is likely to be substantially inhibited by viral
proteinases that cleave MAVS, TRIF and potentially
also the PRRs themselves (36–39). Furthermore, neither
RIG-I nor MDA5 seem capable of inducing responses in
the absence of virus replication and synthesis of dsRNA
replication intermediates (45). Finally, inhibition of RIG-I
and MDA5 expression led to, at best, minimal increases in
E7 replication (Figure 12). This strongly suggests that
neither of these conventional PRRs are primarily respon-
sible for the block on replication of high CpG or UpA
mutants.
Remarkably, however, treatment of cells with C16, gen-
erally considered to be a PKR-speciﬁc inhibitor, led to
substantially enhanced replication of the CpG-high
and UpA-high mutants (90- and 10-fold respectively
greater viral loads compared with untreated cells;
Figure 13). Furthermore, parallel increases in the infectiv-
ity of titred CjC and UjU stocks (Figure 14B) entirely
reversed the phenotypic effect of adding CpG and UpA
dinucleotides to their genomes and restored RNA to in-
fectivity ratios of these mutants to wild-type levels
(Figure 2). Although we initially suspected a role of
PKR in mediating the differential cellular response to E7
variants of different dinucleotide composition, several
competing observations argue against this hypothesis.
Firstly, other inhibitors of PKR expression or function
failed to show a comparable enhancement of CjC and
UjU replication, including a shRNA and a siRNA
directed against PKR and the PKR inhibitor, 2-AP
(Figures 12 and 13). Secondly, another kinase inhibitor,
roscovitine, also enhanced the replication of CjC and UjU
(and strongly suppressed WT virus). This is despite having
no identiﬁed inhibitory activity against PKR and being
largely speciﬁc for the cell cycle regulation proteins,
CDK1, CDK2, CDK5, CDK7 and CDK9 (46,47).
Because C16 has also been shown to also inhibit many
of these kinases (27), one might conjecture that the differ-
ent replication abilities of the E7 mutants may be primar-
ily determined by some aspect of cell cycle regulation.
Replication of at least some enteroviruses is maximally
productive at the G1/S stage of the cell cycle (48,49),
with very recent evidence that nuclear translocation
of enteroviral proteins can prolong the S phase and
enhance productive virus replication (50). Roscovitine
indeed has the effect of arresting cell division in late G1
through inhibition of cdk2/cyclin E and cdk2/cycle A (46).
However, why E7 mutants with increased dinucleotide
frequencies are more sensitive to cell cycle stage than
WT virus would need to be explained. This model also
does not explain why roscovitine and C16 actually in-
hibited the replication of WT and cujcu mutants. Their
inhibition of cdk2 and cdk5 should arrest cells in the
most favourable stage in the cell division cycle for virus
replication.
An intriguing alternative possibility is that there exist
as yet uncharacterized homologues of stress response
proteins that are inhibited by C16 and other kinase
inhibitors. Four proteins are currently known to
induce stress responses through a common pathway by
phosphorylation of eIF2a (51,52). These proteins possess
homologous kinases but distinct recognition domains that
are activated by different stress factors in the endoplasmic
reticulum, including dsRNA (PKR), mis- or unfolded
proteins (PERK) and low amino acid concentrations
(GCN2). Perhaps there exist one or more additional
members of this group that activate the stress response
pathway with further recognition motifs (high CpG or
UpA RNA) and which are also inhibited by C16 (52).
Investigation of cellular binding partners of transfected
RNA of different dinucleotide compositions represents a
promising future approach to identify what proteins are
involved in this recognition process.
The evolutionary basis for dinucleotide frequency biases
in RNA viruses
Although the current study clearly demonstrates the inﬂu-
ence of both CpG and UpA frequencies on virus replica-
tion in cell culture, it invites as many questions as it
answers. The over-riding question is why RNA viruses,
with their extraordinary adaptive abilities, have not
evolved further to reduce CpG and UpA frequencies to
levels lower than they currently are, given the evident rep-
lication advantage this provides at least in cell culture
(Figures 3, 4, and 6–8). The obvious answer must be
that to do so would impair their ﬁtness in their natural
hosts through immune response mechanisms not repre-
sented in ﬁbroblast cell culture. This may include inter-
actions with specialized antigen-presenting cells and
induction of inﬂammatory and adaptive immune re-
sponses that primarily drive the systemic response to
and eventual outcomes of virus infections. Alternatively,
enhanced replication may somehow impair transmission
kinetics in the host population. We have established
equivalent panels of high- and low CpG/UpA mutants
of Theiler’s murine encephalomyelitis virus and H1N1 in-
ﬂuenza A virus for infection of mice to investigate the
effect of dinucleotide frequency changes on in vivo
ﬁtness. The key question to explore is the behaviour of
mutants with lowered dinucleotide frequencies, whether
they achieve greater or lesser degrees of replication
in vivo and separately whether they are attenuated or
show enhanced pathogenicity. Although not formally
investigated to date, if we take the previously described
PV-Max mutant as an example of a virus with suppressed
CpG and UpA frequencies (34), the observed threefold
greater viral titres in brain of peripherally inoculated
mice seems to imply that their suppression confers an
in vivo ﬁtness advantage.
Further in vivo studies are clearly required to place di-
nucleotide frequencies into an appropriate evolutionary
and immunological framework. There is an additional
need to further characterize effects of other nucleotide
and dinucleotide compositional abnormalities of RNA
virus genomes on cellular response. This applies in the
current study to the unexpected enhanced replication of
the UjW E7 mutant (Figure 3) that contrasted with the
otherwise primarily dose-dependent relationship between
dinucleotide composition and replication ability in the
current study (Figures 3 and 4) and in previous mutational
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analyses of poliovirus (17). Recent investigations of the
effect of biased mononucleotide compositions of human
immunodeﬁciency virus type 1 on cellular responses
provide evidence for further complexities in the inter-
action between the viral genomic RNA sequences and
host defences (53,54).
A wide range of other issues remain to be resolved.
While changing UpA frequencies mirrored at least in
part phenotypes induced by altering CpG frequencies, it
remains unclear whether they share recognition mechan-
isms and/or susceptibilities to cellular responses. For
example, UpA (along with UpU) but not CpG is a
preferred target for IFN-induced RNAseL (55,56) and
plays a determining role in mRNA turnover rates (57).
Replication of high UpA mutants was enhanced less by
C16 (Figures 13 and 14) providing some evidence that
cellular recognition mechanisms underlying the replication
phenotypes of UjU and CjC mutants were distinct.
Similarly difﬁcult to account for is the observation that
CpG (and UpA) frequencies are markedly suppressed in
plant viruses even though viral defence mechanisms in
plants are based on entirely different recognition,
signalling and effector pathways from those in mammals.
Uncovering the nature of selection against these dinucleo-
tides in plants will be highly informative in further under-
standing evolutionary processes that govern dinucleotide
compositional constraints in a wider eukaryotic paradigm.
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